/ Report Details / Baculovirus Expression System Market

Baculovirus Expression System Market, By Application (Therapeutic, Research, Industrial), By End-User (Pharmaceutical and Biotechnology companies, Contract research organizations, contract manufacturing organization, Academic research institutes, Others), By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Report Code: AV1686

Industry: Healthcare

Publiced On: 2023-10-16

Pages: 408

Format: ppt pdf

REPORT HIGHLIGHT

Baculovirus Expression System Market size was valued at USD 350.7 Million in 2022, expanding at a CAGR of 9.2% from 2023 to 2030.

The application of the baculovirus expression system has been a longstanding practice in the realm of recombinant protein production within insect cells. In recent times, novel recombinant Baculovirus vectors have emerged, designed for the transient and stable delivery of genes into diverse mammalian cell lines. This dynamic Baculovirus Expression System serves as a versatile and robust platform for manufacturing recombinant proteins, particularly those necessitating precise post-translational modifications. Its capabilities extend beyond protein expression, offering promising prospects for potential medical applications.

Baculovirus Expression System Market- Market Dynamics

  • The high prevalence of lifestyle diseases is expected to propel market demand

The research landscape has witnessed a surge in the exploration of novel proteins, enzymes, and other compounds as potential solutions or diagnostic tools for addressing lifestyle-related ailments. This growing trend underscores the necessity for systems that are capable of producing these proteins in their active configurations, in ample quantities, and with the requisite post-translational modifications. Lifestyle disorders, often referred to as non-communicable diseases (NCDs), encompass a spectrum of conditions such as cardiovascular diseases, diabetes, obesity, and certain cancers. This heightened focus on NCDs has prompted an urgent quest for innovative and efficacious therapeutic approaches.

According to data from the World Health Organization, a staggering 17 million individuals succumb to non-communicable diseases prematurely, annually, before reaching the age of 70. Alarmingly, 86% of these untimely fatalities transpire in low- and middle-income nations. The gravity of this health crisis has instilled a sense of urgency in the pursuit of novel solutions. In parallel, as researchers explore the potential applications of baculoviruses in gene therapy, any breakthroughs in this field could usher in new avenues for business within the Baculovirus Expression System (BES) domain.

Baculovirus Expression System Market- Key Insights

  • Per insights furnished by our research analyst, the global Baculovirus Expression System market is poised for substantial growth, with an estimated Compound Annual Growth Rate (CAGR) of approximately 8.7% during the forecast period spanning from 2023 to 2030.
  • The Baculovirus Expression System industry is set to experience robust expansion, primarily attributed to the burgeoning awareness of sustainable development practices, emphasizing eco-friendly and responsible growth.
  • Delving into the realm of application segmentation, the year 2022 witnessed Therapeutic applications capturing the lion\'s share of the market, showcasing their prevalence and significance.
  • Within the purview of end-user categorization, the pharmaceutical and biotechnology sectors emerged as the predominant categories in 2022, underscoring their pivotal role within the market landscape.
  • Regionally, North America took the lead as the primary revenue contributor in 2022, reflecting its substantial market presence and influence.

Baculovirus Expression System Market- Segmentation Analysis:

The Global Baculovirus Expression System Market exhibits a comprehensive segmentation structure, factored by Application, End-User, and Region.

Application-wise categorization divides the market into three distinct segments: Therapeutic, Research, and Industrial. Among these, the therapeutic segment takes precedence, holding sway over the market landscape. This dominance is underpinned by the Baculovirus Expression System\'s remarkable ability to facilitate the production of therapeutic proteins enriched with mammalian-like post-translational modifications. These specialized modifications are often imperative to render the synthesized proteins not only effective but also safe for therapeutic applications.

Baculovirus Expression System Market- Geographical Insights

This market\'s geographical footprint extends across various regions, encompassing North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within each of these regions, a multitude of nations actively participate in the business landscape, contributing to the market\'s dynamic composition.

Notably, North America is poised to exert its influence on the market\'s expansion, driven by the robust growth of the pharmaceutical and biotechnological sectors within the region. The United States, in particular, stands out as a global leader, with pharmaceutical and biotech companies ranking among the world\'s foremost investors in research and development initiatives.

Baculovirus Expression System Market- Competitive Landscape:

Within the Baculovirus Expression System (BES) market, a diverse array of industry participants offers a spectrum of products, services, and solutions tailored to the specific requirements of BES applications. In this competitive landscape, these entities vie for prominence, leveraging various factors such as product excellence, innovation, pricing competitiveness, and post-purchase support.

Companies are engaged in a relentless pursuit of enhancing the efficiency of their BES offerings, with the aim of achieving heightened yields and elevated protein quality. As the realm of biotechnology research continues to expand globally, especially in emerging domains experiencing surging demand, these organizations are driven to broaden their market presence.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET KEY PLAYERS

  • Thermo Fisher Scientific Inc
  • Promega corporation
  • New England Biolabs
  • Merck Millipore
  • Genscript USA Inc
  • Clontech Laboratories

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY APPLICATION

  • Therapeutic
  • Research
  • Industrial

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY END-USER

  • Pharmaceutical and Biotechnology companies
  • Contract research organizations
  • contract manufacturing organization
  • Academic research institutes
  • Others

GLOBAL BACULOVIRUS EXPRESSION SYSTEM MARKET, BY REGION

  • North America
    • The U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • United Kingdom
    • Russia
    • Netherlands
    • Sweden
    • Poland
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • South Korea
    • Japan
    • Australia
    • Thailand
    • Indonesia
    • Philippines
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Colombia
    • Rest of LATAM
  • The Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Turkey
    • Algeria
    • Egypt
    • Rest of MEA

TABLE OF CONTENT
1. Baculovirus Expression System Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Baculovirus Expression System Market Snippet by Application
2.1.2. Baculovirus Expression System Market Snippet by End-User
2.1.3. Baculovirus Expression System Market Snippet by Country
2.1.4. Baculovirus Expression System Market Snippet by Region
2.2. Competitive Insights
3. Baculovirus Expression System Key Market Trends
3.1. Baculovirus Expression System Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Baculovirus Expression System Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Baculovirus Expression System Market Opportunities
3.4. Baculovirus Expression System Market Future Trends
4. Baculovirus Expression System Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Baculovirus Expression System Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Baculovirus Expression System Market Landscape
6.1. Baculovirus Expression System Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Baculovirus Expression System Market – By Application
7.1. Overview
7.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
7.1.1.1. Therapeutic
7.1.1.2. Research
7.1.1.3. Industrial
8. Baculovirus Expression System Market – By End-User
8.1. Overview
8.1.1. Segment Share Analysis, By End-User, 2022 & 2030 (%)
8.1.1.1. Pharmaceutical and Biotechnology companies
8.1.1.2. Contract research organizations
8.1.1.3. Contract Manufacturing Organization
8.1.1.4. Academic research institutes
8.1.1.5. Others
9. Baculovirus Expression System Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Baculovirus Expression System Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Baculovirus Expression System Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Baculovirus Expression System Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Baculovirus Expression System Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Baculovirus Expression System Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By End-User, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Baculovirus Expression System Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc
10.2.2. Promega corporation
10.2.3. New England Biolabs
10.2.4. Merck Millipore
10.2.5. Genscript USA Inc
10.2.6. Clontech Laboratories
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us

Choose License Type
assit assit

Tailor made solution just for you

80% of our clients seek made-to-order reports. how do you want us to tailor yours?
📧 Talk to Analyst

We have 24/7 dedicated support team.

Get in Touch

© 2023. All rights reserved: AnalystView Market Insights